Spreadsheet: 81ca2089-00a4-4190-aea1-8b0fe69bffbb
Sheet: Sheet1

[NAME] | [NAME] | [NAME] | COG_ONTOLOGY | GOTERM_BP_FAT | GOTERM_CC_FAT | GOTERM_MF_FAT | INTERPRO | KEGG_PATHWAY | PIR_SUPERFAMILY
71874 | RIKEN cDNA 2310007B03 gene | 2310007B03Rik
226245 | RIKEN cDNA 9930023K05 gene | 9930023K05Rik |  |  |  |  | IPR001849:Pleckstrin homology,IPR011993:Pleckstrin homology-type,
12162 | bone morphogenetic protein 7 | Bmp7 |  | GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001654~eye development,GO:0001655~urogenital system development,GO:0001704~formation of primary germ layer,GO:0001707~mesoderm formation,GO:0001763~morphogenesis of a branching structure,GO:0001822~kidney development,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006928~cell motion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~[NAME] receptor protein serine/threonine kinase signaling pathway,GO:0007369~gastrulation,GO:0007389~pattern specification process,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007423~sensory organ development,GO:0007431~salivary gland development,GO:0007435~salivary gland morphogenesis,GO:0007498~mesoderm development,GO:0008285~negative regulation of cell proliferation,GO:0008593~regulation of Notch signaling pathway,GO:0009880~[NAME],GO:0009891~positive regulation of biosynthetic process,GO:0009968~negative regulation of signal transduction,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010648~negative regulation of cell communication,GO:0010721~negative regulation of cell development,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0019220~regulation of phosphate metabolic process,GO:0022612~gland morphogenesis,[NAME]~cell projection organization,GO:0030182~neuron differentiation,GO:0030509~BMP signaling pathway,GO:0030855~epithelial cell differentiation,GO:0031076~embryonic camera-type eye development,[NAME]neuron projection development,[NAME]~positive regulation of cellular biosynthetic process,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0035239~tube morphogenesis,GO:0035272~exocrine system development,GO:0035295~tube development,GO:0040007~growth,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042475~odontogenesis of dentine-containing tooth,GO:0042476~odontogenesis,GO:0042981~regulation of apoptosis,GO:0043010~camera-type eye development,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045746~negative regulation of Notch signaling pathway,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045995~regulation of embryonic development,GO:0048048~embryonic eye morphogenesis,[NAME]~mesoderm morphogenesis,GO:0048562~[NAME] organ morphogenesis,GO:0048568~[NAME] organ development,GO:0048592~eye morphogenesis,GO:0048593~camera-type eye morphogenesis,GO:0048596~[NAME] eye morphogenesis,GO:0048598~[NAME],[NAME]~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048729~tissue morphogenesis,GO:0048732~gland development,GO:0048754~branching morphogenesis of a tube,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0050767~regulation of neurogenesis,GO:0050768~negative regulation of neurogenesis,GO:0051094~positive regulation of developmental process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051216~cartilage development,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051960~regulation of nervous system development,GO:0060284~regulation of cell development,GO:0060348~bone development,GO:0060429~epithelium development,GO:0060445~branching involved in salivary gland morphogenesis,GO:0060685~regulation of prostatic bud formation,GO:0060686~negative regulation of prostatic bud formation,GO:0060687~regulation of branching involved in prostate gland morphogenesis,GO:0060688~regulation of morphogenesis of a branching structure, | GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part, | GO:0001871~pattern binding,GO:0005125~cytokine activity,GO:0005539~glycosaminoglycan binding,GO:0008083~growth factor activity,GO:0008201~heparin binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding, | IPR001111:Transforming growth factor beta (TGFb), N-terminal,IPR001839:Transforming growth factor beta,IPR015615:Transforming growth factor-beta-related,IPR017948:Transforming growth factor beta, conserved site, | mmu04060:Cytokine-cytokine receptor interaction,mmu04340:Hedgehog signaling pathway,mmu04350:TGF-beta signaling pathway, | PIRSF037272:bone morphogenetic protein,PIRSF800009:TGF-beta-like cysteine-knot cytokine,
70574 | carboxypeptidase M | Cpm |  | GO:0006508~proteolysis, | GO:0005886~plasma membrane,GO:0031224~intrinsic to membrane,[NAME]~anchored to membrane, | [NAME]~carboxypeptidase activity,[NAME]metallocarboxypeptidase activity,GO:0008233~peptidase activity,GO:0008235~metalloexopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008238~exopeptidase activity,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides, | IPR000834:Peptidase M14, carboxypeptidase A,IPR014766:Carboxypeptidase, regulatory region, |  | PIRSF009270:carboxypeptidase, M type,PIRSF500885:carboxypeptidase M,
229927 | chloride channel calcium activated 4 | Clca4 |  |  |  |  | IPR002035:[NAME] factor, type A,IPR003961:Fibronectin, type III,IPR004727:Calcium-activated chloride channel protein,IPR013642:Chloride channel calcium-activated,IPR015394:Region of unknown function DUF1973, | mmu04740:Olfactory transduction,
20148 | dehydrogenase/reductase (SDR family) member 3 | Dhrs3 | General function prediction only, | GO:0055114~oxidation reduction, | GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane, |  | IPR002198:Short-chain dehydrogenase/reductase SDR,IPR002347:Glucose/ribitol dehydrogenase,IPR016040:NAD(P)-binding domain, | mmu00830:[NAME] metabolism,
13591 | early B-cell factor 1 | Ebf1 |  | GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0031328~positive regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process, |  | GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding, | IPR001092:Basic helix-loop-helix dimerisation region bHLH,IPR002909:Cell surface receptor IPT/TIG,IPR003523:Transcription factor COE,IPR018350:Transcription factor COE, conserved site, |  | PIRSF018314:transcription factor, collier type,
15375 | forkhead box [NAME]; similar to [NAME] nuclear factor 3-alpha (HNF-3A) (Forkhead box protein A1) | Foxa1 |  | GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001655~urogenital system development,GO:0001708~cell fate specification,GO:0001763~morphogenesis of a branching structure,GO:0002009~morphogenesis of an epithelium,GO:0002064~epithelial cell development,[NAME]/cuboidal epithelial cell differentiation,GO:0002067~glandular epithelial cell differentiation,GO:0002070~epithelial cell maturation,GO:0003006~reproductive developmental process,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,[NAME]cell-cell signaling,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,[NAME]negative regulation of gene expression,GO:0010817~regulation of hormone levels,GO:0016481~negative regulation of transcription,GO:0021700~developmental maturation,GO:0022612~gland morphogenesis,GO:0030182~neuron differentiation,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0030850~prostate gland development,GO:0030855~epithelial cell differentiation,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0033500~carbohydrate homeostasis,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0042445~hormone metabolic process,GO:0042592~homeostatic process,GO:0042593~glucose homeostasis,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0045597~positive regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048469~cell maturation,GO:0048608~reproductive structure development,GO:0048610~reproductive cellular process,GO:0048663~neuron fate commitment,GO:0048665~neuron fate specification,GO:0048729~tissue morphogenesis,GO:0048732~gland development,GO:0048754~branching morphogenesis of a tube,GO:0048878~chemical homeostasis,GO:0050767~regulation of neurogenesis,GO:0051094~positive regulation of developmental process,[NAME]~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051960~regulation of nervous system development,GO:0060284~regulation of cell development,GO:0060429~epithelium development,GO:0060512~prostate gland morphogenesis,GO:0060525~prostate glandular acinus development,GO:0060528~secretory columnal [NAME] cell differentiation involved in prostate glandular acinus development,GO:0060541~respiratory system development,GO:0060684~epithelial-mesenchymal cell signaling,GO:0060738~epithelial-mesenchymal signaling involved in prostate gland development,GO:0060740~prostate gland epithelium morphogenesis,GO:0060741~prostate gland stromal morphogenesis,GO:0060742~epithelial cell differentiation involved in prostate gland development,GO:0060743~epithelial cell maturation involved in prostate gland development, |  | GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008134~transcription factor binding,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding, | IPR001766:Transcription factor, fork head,[NAME]:Winged helix repressor DNA-binding,[NAME]:Fork-head N-terminal,IPR018122:Transcription factor, fork head, conserved site,IPR018533:Forkhead box protein, C-terminal, |  | PIRSF001732:transcription factor [NAME],
50917 | galactosamine (N-acetyl)-6-sulfate sulfatase | Galns |  |  | GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005773~vacuole, | GO:0005509~calcium ion binding,GO:0008484~sulfuric ester hydrolase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043890~N-acetylgalactosamine-6-sulfatase activity,GO:0046872~metal ion binding, | IPR000917:Sulfatase,[NAME]:Alkaline phosphatase-like, alpha/beta/alpha, | mmu00531:Glycosaminoglycan degradation,mmu04142:Lysosome, | PIRSF000971:animal sulfatase,
15473 | heat-responsive protein 12 | Hrsp12 |  |  | [NAME]~mitochondrion, | GO:0004518~nuclease activity,GO:0004519~endonuclease activity, | IPR006056:YjgF-like protein,IPR006175:Endoribonuclease L-PSP,IPR013813:Endoribonuclease L-PSP/chorismate mutase-like,IPR019897:YjgF-like protein, conserved site,
16398 | [NAME] 2 | Itga2 |  | GO:0007155~cell adhesion,GO:0007166~cell surface receptor linked signal transduction,[NAME]~[NAME] signaling pathway,GO:0022610~biological adhesion, | GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0008305~[NAME],[NAME]~external side of plasma membrane,[NAME]cell surface,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0043235~receptor complex,GO:0044459~plasma membrane part, | [NAME]~magnesium ion binding,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding, | IPR000413:Integrin alpha chain,[NAME]:[NAME] factor, type A,IPR013513:Integrin alpha chain, C-terminal, cytoplasmic region,IPR013517:FG-GAP,IPR013519:Integrin alpha beta-propellor,IPR013649:[NAME]:Integrin alpha chain, C-terminal cytoplasmic region, conserved site, | mmu04510:Focal adhesion,mmu04512:ECM-receptor interaction,mmu04640:Hematopoietic cell lineage,mmu04810:Regulation of actin cytoskeleton,mmu05200:Pathways in cancer,mmu05222:Small cell lung cancer,mmu05410:[NAME] cardiomyopathy (HCM),mmu05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),mmu05414:Dilated cardiomyopathy, | PIRSF002497:integrin alpha with I domain,PIRSF501013:[NAME],
242721 | kelch domain containing 7A | [NAME] |  |  | GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane, |  | IPR006652:Kelch repeat type 1,IPR013089:Kelch related,IPR015915:Kelch-type beta propeller,
16819 | lipocalin 2 | Lcn2 |  | GO:0009615~response to virus, | GO:0005576~extracellular region, |  | IPR000566:Lipocalin-related protein and Bos/Can/Equ allergen,IPR002345:Lipocalin,IPR003087:Neutrophil gelatinase-associated lipocalin,IPR012674:Calycin, |  | PIRSF002514:lipocalin,PIRSF500262:neutrophil gelatinase-associated lipocalin,
18162 | natriuretic peptide receptor 3 | Npr3 |  | GO:0003013~circulatory system process,GO:0006140~regulation of nucleotide metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007187~G-protein signaling, coupled to cyclic nucleotide second messenger,[NAME]~G-protein signaling, coupled to cAMP nucleotide second messenger,GO:0007193~inhibition of adenylate cyclase activity by G-protein signaling,GO:0007194~negative regulation of adenylate cyclase activity,GO:0007200~activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger,GO:0007202~activation of phospholipase C activity,GO:0007242~intracellular signaling cascade,GO:0008015~blood circulation,GO:0008217~regulation of blood pressure,GO:0010517~regulation of phospholipase activity,GO:0010518~positive regulation of phospholipase activity,GO:0010863~positive regulation of phospholipase C activity,GO:0019932~second-messenger-mediated signaling,GO:0019933~cAMP-mediated signaling,GO:0019935~cyclic-nucleotide-mediated signaling,GO:0030799~regulation of cyclic nucleotide metabolic process,GO:0030802~regulation of cyclic nucleotide biosynthetic process,GO:0030808~regulation of nucleotide biosynthetic process,GO:0030814~regulation of cAMP metabolic process,GO:0030817~regulation of cAMP biosynthetic process,GO:0031279~regulation of cyclase activity,GO:0031280~negative regulation of cyclase activity,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0045761~regulation of adenylate cyclase activity,GO:0048015~phosphoinositide-mediated signaling,GO:0051336~regulation of hydrolase activity,GO:0051339~regulation of lyase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051350~negative regulation of lyase activity,GO:0060191~regulation of lipase activity,GO:0060193~positive regulation of lipase activity, | [NAME]cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane, | GO:0001653~peptide receptor activity,GO:0008528~peptide receptor activity, G-protein coupled,GO:0017046~peptide hormone binding,GO:0031404~chloride ion binding,GO:0042277~peptide binding,GO:0042562~hormone binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043167~ion binding,GO:0043168~anion binding,GO:0046983~protein dimerization activity, | IPR001170:Natriuretic peptide receptor, N-terminal,IPR001828:Extracellular ligand-binding receptor, |  | PIRSF001970:natriuretic peptide receptor C,
57349 | pro-platelet basic protein | Ppbp |  | GO:0006955~immune response, | GO:0005576~extracellular region, | GO:0005125~cytokine activity,GO:0008009~chemokine activity,GO:0042379~chemokine receptor binding, | IPR001089:Small chemokine, C-X-C,IPR001811:Small chemokine, interleukin-8-like,IPR002473:Small chemokine, C-X-C/Interleukin 8, | mmu04060:Cytokine-cytokine receptor interaction,mmu04062:Chemokine signaling pathway, | PIRSF002522:CXC chemokine,
20753 | small proline-rich protein 1A | Sprr1a |  | GO:0007398~ectoderm development,GO:0008544~epidermis development,GO:0009913~epidermal cell differentiation,GO:0030216~keratinocyte differentiation,GO:0030855~epithelial cell differentiation,GO:0031424~keratinization,GO:0060429~epithelium development, |  |  | IPR003267:Small proline-rich,IPR003302:Cornifin (SPRR),
224674 | solute carrier family 37 (glycerol-3-phosphate transporter), member 1 | Slc37a1 | Carbohydrate transport and metabolism, |  |  |  | IPR011701:Major facilitator superfamily MFS-1,
81840 | sortilin-related VPS10 domain containing receptor 2 | Sorcs2 |  |  | GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane, |  | IPR000601:PKD,IPR006581:[NAME],
21961 | tensin 1 | Tns1 |  | GO:0006928~cell motion,GO:0007044~cell-substrate junction assembly,GO:0016477~cell migration,GO:0034329~cell junction assembly,GO:0034330~cell junction organization,GO:0048870~cell motility,GO:0051674~localization of cell, | GO:0005886~plasma membrane,GO:0005912~adherens junction,[NAME]cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0016323~basolateral plasma membrane,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0044459~plasma membrane part,GO:0070161~anchoring junction, | [NAME],GO:0008092~cytoskeletal protein binding, | IPR000980:SH2 motif,IPR006020:Phosphotyrosine interaction region,IPR013625:[NAME] phosphotyrosine-binding domain,IPR014019:Phosphatase tensin type,
100647 | uroplakin 3B | Upk3b |  |  | GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,